Summary
Pituitary incidentalomas are circumscribed regions of decreased opacity observed in pituitary CT or MRI exams performed in the absence of suspected pituitary disease. Most incidentalomas are pituitary adenomas, although they can be virtually any type of sellar mass. Most are <1 cm in diameter and can be considered microincidentalomas. The incidence of incidentalomas in MRI studies is approximately 10%, similar to the overall incidence of microadenomas in autopsy series. Only a very small percentage (<1%) of incidentalomas are hormonally active, with the most common being prolactinomas. The progression of incidentalomas to clinically significant lesions is infrequent but appears to be greater for nonfunctioning tumors than for pituitary cysts. Screening for hormonal hyperfunction should be based on the clinical suspicion of pituitary disease, and prolactin measurement alone appears to be the most cost-effective strategy for microincidentalomas. Macroincidentalomas have greater growth potential and are more frequently associated with hypopituitarism. Management of incidentalomas unassociated with hormonal disturbances and no increase in size can be conservative. In those with hormonal deficiencies, a more-proactive role can be justified because hypopituitarism is often reversible with removal of the tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Molitch ME, Russell EJ. The pituitary “incidentaloma”. Ann Intern Med 1990;112:925–31.
Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 1997;26:233–53.
Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 2003;149:123–7.
Fainstein Day P, Guitelman M, Artese R, et al. Retrospective multicentric study of pituitary incidentalomas. Pituitary 2005;7:1–4.
Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas – results of a prospective study. Clin Endocrinol (Oxf) 1999;51:109–13.
Terramoto A, Hirakawa K, Sanno N, Osamura Y. Incidental pituitary lesions in 10000 unselected autopsy specimens. Radiology 1994;193:161–4.
Chambers EF, Turski PA, LaMasters D, Newton TH. Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 1982;144:109–13.
Chong BW, Kucharczyk W, Singer W, George S. Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. AJNR Am J Neuroradiol 1994;15:675–79.
Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817–20.
Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999;282:36–9.
CBTRUS (2005). Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Hinsdale, IL, Central Brain Tumor Registry of the United States; 2006.
Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156–8.
Kovacs K, Corenblum B, Sirek AM, Penz G, Ezrin C. Localization of prolactin in chromophobe pituitary adenomas: study of human necropsy material by immunoperoxidase technique. J Clin Pathol 1976;29:250–8.
Miyai K, Ichihara K, Kondo K, Mori S. Asymptomatic hyperprolactinaemia and prolactinoma in the general population – mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986;25:549–4.
Miyake A, Ikegami M, Chen CF, et al. Mass screening for hyperprolactinemia and prolactinoma in men. J Endocrinol Invest 1988;11:383–4.
King JT, Jr, Justice AC, Aron DC. Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab 1997;82:3625–32.
Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf ) 1980;12:71–9.
Bengtsson B-A, Eden S, Ernest I, Oden A, Sjoegren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327–35.
Annegers JF, Coulam CB, Abboud CF, Laws ER, Jr, Kurland LT. Pituitary adenoma in Olmsted County, Minnesota, 1935–1977. A report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc 1978;53:641–3.
Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994;40:479–84.
Greenman Y, Trostanetsky Y, Somjen D, Tordjman K, Kohen F, Stern N. Effect of TRH on beta-gonadotropin subunits in patients with pituitary microincidentalomas. Eur J Endocrinol 1999;141:17–21.
March CM, Kletzky OA, Davajan V, et al. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 1981;139:835–44.
Weiss MH, Teal J, Gott P, et al. Natural history of microprolactinomas: six-year follow-up. Neurosurgery 1983;12:180–3.
Koppelman MC, Jaffe MJ, Rieth KG, Caruso RC, Loriaux DL. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. Ann Intern Med 1984;100:115–21.
Sisam D, Redmond G, Sheeler L. The natural history of untreated hyperprolactinemias. Fertil Steril 1987;48:67–72.
Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989;68:412–8.
Oyama K, Sanno N, Tahara S, Teramoto A. Management of pituitary incidentalomas: according to a survey of pituitary incidentalomas in Japan. Semin Ultrasound CT MR 2005;26:47–50.
Wolpert SM, Molitch ME, Goldman JA, Wood JB. Size, shape, and appearance of the normal female pituitary gland. AJR Am J Roentgenol 1984;143:377–81.
Peyster RG, Adler LP, Viscarello RR, Hoover ED, Skarzynski J. CT of the normal pituitary gland. Neuroradiology 1986;28:161–5.
Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W. The ‘incidentaloma’ of the pituitary gland: Is neurosurgery required. JAMA 1990;263:2772–6.
Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995;155:181–3.
St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 1996;44:305–9.
Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002;87:3537–42.
Findling JW, Raff H. Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2005;34:385–402.
Howlett TA, Como J, Aron DC. Management of pituitary incidentalomas. A survey of British and American endocrinologists. Endocrinol Metab Clin North Am 2000;29:223–30.
Aron DC, Howlett TA. Pituitary incidentalomas. Endocrinol Metab Clin North Am 2000;29:205–21.
Arafah BM. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986;62:1173–79.
Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000;85:1789–93.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Frohman, L.A. (2008). Management of Pituitary Incidentalomas. In: Swearingen, B., Biller, B.M. (eds) Diagnosis and Management of Pituitary Disorders. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-264-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-59745-264-9_21
Publisher Name: Humana Press
Print ISBN: 978-1-58829-922-2
Online ISBN: 978-1-59745-264-9
eBook Packages: MedicineMedicine (R0)